Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to investigate the
efficacy (e.g. glycemic control) and safety (e.g. hypoglycemic episodes) when adding
repaglinide to a monotherapy of metformin in type 2 diabetic patients under normal clinical
practice